Stockreport

FDA will not meet ahead of bluebird bio's sickle cell disease gene therapy PDUFA date [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Administration (FDA) will not schedule an advisory committee meeting (FDA) to discuss the therapy. An approval decision can now be expected for lovo-cel or lovotibeglo [Read more]